Literature DB >> 21228363

Hormone receptor status rather than HER2 status is significantly associated with increased Ki-67 and p53 expression in triple-negative breast carcinomas, and high expression of Ki-67 but not p53 is significantly associated with axillary nodal metastasis in triple-negative and high-grade non-triple-negative breast carcinomas.

Jeong S Han1, Dengfeng Cao, Kyle H Molberg, Venetia R Sarode, Roshni Rao, Lisa M Sutton, Yan Peng.   

Abstract

Triple-negative (TN) breast carcinoma is associated with a higher recurrence rate and shorter survival and lacks the benefit of specific therapy. TN tumors usually express high levels of Ki-67 and p53 that are considered prognostic markers for breast cancer. We compared Ki-67 and p53 expression between TN and high-grade non-TN invasive carcinomas in a total of 214 cases and investigated an association between their expression and axillary nodal metastasis in these tumors. Our findings demonstrate that TN tumors are associated with significantly higher expression of Ki-67 and p53 compared with non-TN tumors, which may contribute to the poorer prognosis in TN tumors. Hormone receptor negativity rather than HER2 negativity is associated with the significantly increased Ki-67 and p53 expression in TN tumors. Furthermore, a high expression level of Ki-67 but not p53 is more likely to be associated with axillary nodal metastasis in these cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228363     DOI: 10.1309/AJCP9DV3EVZUATFV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Prognostic effect of p53 expression in patients with completely resected colorectal cancer.

Authors:  Bin-Wei Liu; Yang Liu; Jun-Ru Liu; Zhong-Xu Feng; Tong Liu
Journal:  Tumour Biol       Date:  2014-07-04

2.  MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival.

Authors:  Brian C Grieb; Xi Chen; Christine M Eischen
Journal:  Mol Cancer Res       Date:  2014-05-27       Impact factor: 5.852

3.  Expression of calretinin in high-grade hormone receptor-negative invasive breast carcinomas: correlation with histological and molecular subtypes.

Authors:  Donata Micello; Alberto Bossi; Alessandro Marando; Emanuele Dainese; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2017-05-26       Impact factor: 4.064

4.  Expression and Clinical Significance of Claudin-7, PDL-1, PTEN, c-Kit, c-Met, c-Myc, ALK, CK5/6, CK17, p53, EGFR, Ki67, p63 in Triple-negative Breast Cancer-A Single Centre Prospective Observational Study.

Authors:  Chloe Constantinou; Savvas Papadopoulos; Eirini Karyda; Athanasios Alexopoulos; Niki Agnanti; Anna Batistatou; Haris Harisis
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

5.  Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples.

Authors:  Anna Dvorkin-Gheva; John A Hassell
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

6.  Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer.

Authors:  Sei Hyun Ahn; Hwa Jung Kim; Wonshik Han; Jihyoung Cho; Gyungyub Gong; Kyung Hae Jung; Sung-Bae Kim; Byung Ho Son; Jong Won Lee
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

7.  Overexpression of Raf-1 in basal-like carcinoma of the breast: correlation with clinicopathology and prognosis.

Authors:  Ping Wu; Xizhou Li; Yangmei Wu; Wei Hu; Yang Wang; Li Gao; Zhongzhong Chen; Weiqiang Zheng
Journal:  Contemp Oncol (Pozn)       Date:  2014-12-03

Review 8.  Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.

Authors:  Claudia Omarini; Giorgia Guaitoli; Stefania Pipitone; Luca Moscetti; Laura Cortesi; Stefano Cascinu; Federico Piacentini
Journal:  Cancer Manag Res       Date:  2018-01-15       Impact factor: 3.989

9.  A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.

Authors:  Liang Huang; Zhebin Liu; Sheng Chen; Yin Liu; Zhiming Shao
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

10.  CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.

Authors:  Bray Denard; Sharon Jiang; Yan Peng; Jin Ye
Journal:  BMC Cancer       Date:  2018-08-13       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.